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Prompt and efficient clearance of apoptotic cells is necessary to prevent secondary necrosis of dying cells
and to avoid immune responses to autoantigens. Recent studies have shed light on how apoptotic cells
through soluble ‘‘find-me’’ signals advertise their presence to phagocytes at the earliest stages of cell death.
Phagocytes sense the find-me signal gradient, and in turn the presence of dying cells, and migrate to their
vicinity. The apoptotic cells also expose specific ‘‘eat-me’’ signals on their surface that are recognized by
phagocytes through specific engulfment receptors. This review covers the recent progress in the areas of
find-me and eat-me signals and how these relate to prompt and immunologically silent clearance of apoptotic
cells.We turn over billions of cells as part of normal homeostasis every
day (1 million cells per second) (Henson, 2005; Nagata et al.,
2010). The cells that are targeted for turnover can fall into several
classes (Ravichandran and Lorenz, 2007). Excess cells are often
generated as part of normal development or tissuemaintenance,
e.g., in the thymus during maturation of T cells, in the bone
marrow during generation of neutrophils and other myeloid cells,
in the testes during generation of germ cells, involution of
mammary glands after lactation, or in specific niches of the brain
as part of adult neurogenesis. Only a few of these newly gener-
ated cells survive or are considered fit enough to mature further;
the rest die and their corpses need to be cleared. Another situa-
tion requiring corpse removal is that many aged or used cells are
removed on a daily basis in many tissues; some examples
include red blood cells and ‘‘spent’’ rod cells in the eye. Also,
damaged cells arise in many tissues resulting from either
encounter with the environment, e.g., air pollution (airway epithe-
lial cells), ultraviolet radiation (skin), or DNA damage as part of
meiosis (germ cells). The dying cells are quickly recognized
and removed by phagocytes, which can be either neighboring
healthy cells or professional phagocytes recruited to sites of
apoptotic cell death.
Over the past two decades, enormous strides have been
made toward understanding various mechanisms of pro-
grammed cell death at the level of the dying cell (Gregory and
Pound, 2011; Nagata et al., 2010). In vivo, the death process is
closely linked to the removal of the corpses (Gregory and Pound,
2011). Failure to properly clear dying cells has been linked to
nonresolving inflammation, many autoimmune conditions, and
developmental abnormalities (Hanayama et al., 2006; Mun˜oz
et al., 2010; Nagata et al., 2010; Nathan and Ding, 2010). It could
be argued that prompt, efficient, and immunologically silent
clearance of dying cells is perhaps the ultimate goal of the cell
death program. It is noteworthy that many modalities of cell
death have been described depending on morphological,
biochemical, and other features of the dying cells, including
caspase-dependent and -independent apoptosis, regulated
necrosis, cell death associated with autophagy, and mitoticcatastrophe (Galluzzi et al., 2011). However, depending on the
nature of induction of death, the cell type, and tissue context,
a dying cell may show distinct, as well as overlapping or mixed
features, of cell death (Galluzzi et al., 2009). Because we have
learned relatively more about removal of cells dying via cas-
pase-dependent apoptosis, this review primarily focuses on
our understanding clearance of these apoptotic cells.
Several distinguishable steps have been recognized in the
engulfment and clearance of apoptotic cells. The phagocytes
and the dying cells have to be in proximity, which is achieved
through find-me signals (Peter et al., 2010b); the phagocytes
then specifically engage the dying cells, achieved via eat-me
signals on dying cells and receptors for the eat-me signals on
phagocytes (Gardai et al., 2006); the phagocytes then physically
engulf the dying cells through signaling induced by engulfment
receptors and cytoskeletal reorganization of the phagocyte
membrane (Ravichandran and Lorenz, 2007); and lastly, the
corpse contents have to be processed within the phagocytes
through phagolysosomal processing (Kinchen et al., 2008; Kin-
chen and Ravichandran, 2008; Park et al., 2011; Zhou and Yu,
2008). In recent years, several new discoveries have been re-
ported on all of the above aspects of engulfment. This review
specifically covers recent discoveries that pertain to find-me
and eat-me signals and how they relate to engulfment.
Find-Me Signals: The Altruistic Suicide Notes
How Do Apoptotic Cells Advertise Their Presence?
It has long been observed by many investigators that even in
tissues with known high turnover of cells (e.g., thymus, bone
marrow, or testes), few apoptotic cells are seen in the steady
state. However, when the apoptotic cell clearance process is
disrupted, for example through genetic ablation of engulfment
genes or pharmacological approaches that inhibit cell clearance,
there is an accumulation of uncleared corpses that becomes
readily apparent (Elliott et al., 2010; Henson, 2005; Lu et al.,
2011; Nagata et al., 2010). This suggests that in the steady state,
the apoptotic cell clearance machinery is quick and efficient,
such that the dying cells are sensed, recognized, and clearedImmunity 35, October 28, 2011 ª2011 Elsevier Inc. 445
Figure 1. Find-Me Signals in Phagocyte Attraction
The known find-me signals released by apoptotic cells are depicted. Of these,
the nucleotides and P2Y2 and the CX3CL1 and CX3CR1 modules have been
shown to be operational in vivo, but the roles of S1P and LPC remain to be
established in an in vivo model. The receptor LPC, although suggested to be
G2A, is unclear and remains to be proven.
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collector until there is a disruption in trash collection and we
begin to notice the unpleasant odor. Similarly, as long as the
engulfment machinery is intact and functional, uncleared
apoptotic cells are not evident; however, disruption of cell clear-
ance leads to accumulation of secondarily necrotic corpses in
tissues often associated with autoimmunity toward self-antigens
derived from the uncleared corpses (Franz et al., 2006). This
implies that the apoptotic cells must somehow ‘‘advertise’’ their
presence at the earliest stages of death to promote clearance.
The very close link between cells beginning to die and their quick
and efficient removal came first from genetic studies in
C. elegans. By using a mutant background where the caspase-
mediated apoptosis was partially impaired, two groups (Hoepp-
ner et al., 2001; Reddien et al., 2001) elegantly demonstrated
that even under these partial death circumstances, if the engulf-
ment machinery was intact, these ‘‘partially dead’’ cells are effi-
ciently recognized and removed; however, when the engulfment
machinery is also impaired, then the partially dead cells abort the
death program. This strongly suggests that the phagocytes are
extremely efficient in sensing and detecting the dying cells at
the earliest stages of apoptosis and contribute to the ‘‘final
stages’’ of death.
In the above-mentioned C. elegans studies, the phagocytes
are often the healthy neighbors. In the context of mammalian
cells, this is often not the case. For example, in the thymus,
a dying thymocyte is unlikely to be engulfed by a neighboring
healthy thymocyte (because immature thymocytes lack the cyto-
plasmic volume and cytoskeletal machinery to ingest another
cell of the similar size); rather, a resident macrophage or a
dendritic cell within the thymus is more likely to mediate the
clearance (Ravichandran, 2003). In such a case, the dying cell
must be able to advertise its state of death and in turn recruit
a phagocyte to its proximity. This led to the concept of soluble
find-me signals being released by apoptotic cells. Such soluble
mediators would then set up a gradient within the tissue to
attract the phagocytes to the proximity of the dying cells. The
current notion is that the find-me signals, released by the dying
cells at the earliest stages of apoptosis, would then be sensed446 Immunity 35, October 28, 2011 ª2011 Elsevier Inc.by the phagocytes via receptors, and subsequent signaling
within the phagocytes would induce the migration to the prox-
imity of the dying cells (Peter et al., 2010a).
Specific Find-Me Signals, Their Release from Apoptotic
Cells, and Sensing by Phagocytes
In the past few years, four possible find-me signals released from
apoptotic cells have been reported: the lipid lysophosphatidyl-
choline (LPC), sphingosine 1-phosphate (S1P), the fractalkine
CX3CL1, and the nucleotides ATP and UTP (Figure 1). Remark-
ably, these are different types of molecules, yet they are all linked
to monocyte or macrophage recruitment toward apoptotic cells.
The discussion below focuses on what we currently know about
the generation and release of these find-me signals, how phago-
cytes sense them, and whether or not they have been proven to
be of relevance in vivo.
Lauber et al. (2003) identified LPC as a find-me signal released
by MCF-7 breast cancer cells based on the ability of their
apoptotic cell supernatants to attract the THP-1 monocytic cell
line. Few other cell lines and different modes of apoptosis could
lead to the release of LPC, but the MCF-7 cells were the best
characterized. The authors also went on to show elegantly that
the calcium-independent phospholipase A2 (iPLA2), upon
cleavage by caspases, is probably responsible for the release
of LPC from the dying cells (Lauber et al., 2003). This study
brought the idea of find-me signals to the fore and that caspase-
dependent release of soluble mediators could act as find-me
signals to recruit monocytes from circulation into tissues with
apoptotic cells. However, a number of interesting questions
were raised by this work. The first is the challenge of LPC setting
up a concentration gradient. The concentration of LPC released
byMCF-7 cells (at least as detected in the assay system) is small
(Lauber et al., 2003). Because there is a high concentration of
LPC in the serum or plasma (100 mM), it is unclear how LPC
can set up a gradient to attract phagocytes specifically to the
proximity of apoptotic cells. Although high concentration of
LPC could be present locally near a dying cell and thereby still
provide the gradient, higher LPC concentrations cause lysis of
many cells. Perhaps LPC is not recognized in its native form,
but rather is bound to other serum components (and therefore
effectively unavailable) and further modified in tissues, or LPC
may function together with another soluble mediator(s). The
second challenge with LPC as a find-me signal is that G2A (Peter
et al., 2008), the receptor that is linked to LPC recognition by
phagocytes, has been controversial and the validity of the orig-
inal identification of G2A as the receptor for LPC is questionable
(Witte et al., 2005). Therefore, the specific receptor on phago-
cytes that mediates LPC-dependent movement toward
apoptotic cells remains to be determined. The third challenge
is that the role of LPC as a find-me signal in vivo is not yet estab-
lished. Although the original studies clearly show that LPC can
act as a find-me signal in vitro (Lauber et al., 2003), complemen-
tary in vivo studies of LPC-dependent recruitment of phagocytes
to apoptotic cells remain to be established.
The soluble molecule sphingosine 1-phosphate (S1P) has also
been proposed as a find-me signal (Gude et al., 2008; Weigert
et al., 2010). Gude et al. (2008) suggested that induction of
apoptosis results in upregulation of S1P kinase 1 (SphK1). The
increased SphK1 was then linked to generation of S1P and
in turn S1P-dependent recruitment of macrophages to the
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that S1P kinase 2 (SphK2) itself is a target of caspase 1 and that
the cleaved fragment of SphK2 could be ‘‘released’’ from dying
cells into the extracellular space where it would generate S1P
(Weigert et al., 2010). Given the well-known role of S1P as
a migratory signal and the pharmacological interest in modifying
S1P-based signals, this observation is potentially very inter-
esting. However, a number of key issues need to be resolved.
First, all of the work to date suggesting S1P as a find-me signal
has been done in vitro, and the relevance of S1P in recruiting
phagocytes to apoptotic cells in vivo has not been determined.
Staurosporine-induced cell death has been shown to induce
caspase-1 and in turn cleavage of SphK2 (Weigert et al., 2010).
However, caspase-1 is normally not induced during other forms
of apoptosis and the mechanism for S1P generation remains to
be better defined. With respect to sensing of S1P, it can be
recognized by the receptors S1P1 through S1P5, yet which of
these G protein-coupled receptors (GPCRs) are relevant for
phagocytic recruitment to apoptotic cells is not known. Both
sphingosine kinase 1 and 2 have been linked to S1P generation
during apoptosis (Gude et al., 2008; Weigert et al., 2010),
but presumably by distinct mechanisms: SphK1 protein level
being increased during apoptosis versus cleavage of SphK2 by
caspases. Because genetically targeted mice exist for both
Sphk1 and Sphk2, the specific enzyme question as well as the
relevance of S1P as find-me signal should be addressable in
an organismal context. Collectively, although S1P could serve
as a find-me signal in vitro, its relevance in vivo, the receptors
on phagocytes that help mediate recruitment to apoptotic cells,
and the relative importance of S1P compared to other find-me
signals need to be determined.
In addition to the two lipid mediators referred to above,
a soluble fragment of fractalkine (CX3CL1) protein can also serve
as a find-me signal for monocytes (Truman et al., 2008). Chris
Gregory and colleagues (Truman et al., 2008) demonstrated
that a soluble chemokine fragment of fractalkine, which is
normally on the plasma membrane and serves as an intercellular
adhesion molecule, is released as a 60 kDa fragment during
apoptosis and can act as a chemoattractant. CX3CL1 release
is caspase dependent, although it may not be direct (the
cleavage being more probably done by extracellular ADAM
protease family members). Truman et al. (2008) also suggested
that fractalkine (CX3CL1) is released as part of microparticles
from early stages of apoptotic Burkitt Lymphoma cells (which
are the malignant version of the germinal center B cells).
CX3CR1, the receptor for CX3CL1, appeared important in
sensing the chemokine and for inducing monocyte migration
both in vitro and in vivo. Mice lacking CX3CR1 show a defect
in the migration of macrophages to the germinal centers, where
a high rate of apoptosis takes place. Although the authors clearly
acknowledge that the fractalkine might be more specific for
Burkitt Lymphoma or germinal center B cells, this work through
its in vivo studies with CX3CR1 establishes fractalkine (CX3CL1)
as a bona fide find-me signal.
The latest to join the find-me signal mediators are the nucleo-
tides found in the supernatants of apoptotic cells. Elliott et al.
(2009) demonstrated that the regulated release of triphosphate
nucleotides ATP and UTP from early apoptotic cells can potently
attract monocytes both in vitro and in vivo. Nucleotide releasewas shown to occur in Jurkat cells, primary thymocytes, MCF-7
cells, and lung epithelial cells after apoptosis induction via
multiple modalities (crosslinking Fas, UV treatment, etoposide,
etc.) and is dependent on caspase activity. Interestingly, less
than2%of thecellular ATP is released fromearly-stage apoptotic
cells when their plasma membrane is still intact. The released
nucleotides in the apoptotic cell supernatants are ‘‘chemotactic’’
for monocytes (i.e., inducing directional migration) rather than
promoting ‘‘chemokinesis’’ (i.e., random migration).
Importantly, the apoptotic cell supernatants injected into
a mouse dorsal airpouch could preferentially attract monocytes
and this recruitment is abolished when the triphosphonucleoti-
des from the supernatants were degraded (Elliott et al., 2009).
Furthermore, with clearance of dying thymocytes (after dexa-
methasone-induced apoptosis in the thymus) as a readout,
enzymatically ablating the nucleotides or blocking nucleotide
recognition by phagocytes results in uncleared corpses in this
in vivo model. The sensing of the released extracellular nucleo-
tides was shown to involve the P2Y family of nucleotide recep-
tors; more specifically, the P2Y2 member is relevant for sensing
of nucleotides by monocytes both in vitro and in the context of
P2Y2 genetically ablatedmice. Collectively, these data identified
release of the nucleotides ATP and UTP by early-stage apoptotic
cells and their sensing via P2Y2 on monocytes and that this find-
me signal circuit is relevant for apoptotic cell clearance in vivo.
As with other studies, a number of challenges remain in
defining the role of nucleotides as a find-me signal. Extracellular
nucleotides are often degraded by nucleotide triphosphatases
(NTPases) (Knowles, 2011; Schetinger et al., 2007). Given the
small amount of ATP released (about 100 nM or 2%), it is
unclear how a nucleotide gradient would be established and
what distances such a gradient may be able to ‘‘travel’’ to attract
phagocytes. The in vivo data in the airpouch model and the
thymocyte clearance model suggest that a relevant gradient
can be established by this amount of ATP and recognized by
monocytes (Elliott et al., 2009), but the distance for this ‘‘final
call’’ remains unknown. Also, the NTPdases are expressed at
different amounts in various tissues (Knowles, 2011; Schetinger
et al., 2007) and therefore may further regulate the distance for
the attraction signal. It is noteworthy, however, that diphosphate
nucleotides (ADP or UDP), monophosphate (AMP), or adenosine
show very poor chemotactic activity, suggesting that it is the
triphosphates that were acting as find-me signals (Elliott et al.,
2009). Another challenge is that although P2ry2-ablated mice
clearly show a defect in attracting monocytes (Elliott et al.,
2009), there was still residual migration in thesemice, suggesting
that other P2Y family members may also play a role. Further-
more, the signaling downstream of the P2Y receptors and the
specific signaling that induces migration of monocytes remains
to be determined. Nevertheless, nucleotides represent one of
the better-understood find-me signals at this point.
In addition to the above four signalingmolecules, the release of
ribosomal protein S19 (which dimerizes during apoptosis and
binds to the complement receptor for C5a on monocytes) has
beensuggested asafind-mesignal (Yamamoto, 2007).However,
it appears that S19 is probably released at very late stages of
apoptosis. Also, a fragment of the tyrosyl tRNA synthetase (EMA-
PII) released from apoptotic cells has been shown to attract
monocytes (Shalak et al., 2001). Surprisingly, EMAPII hasImmunity 35, October 28, 2011 ª2011 Elsevier Inc. 447
Figure 2. A Balance between Find-Me Signals and Keep-Out Signals
Apoptotic cells release both find-me and keep-out signals that help prefer-
entially recruit monocytes or noninflammatory cells over neutrophils. Lacto-
ferrin is identified as one of the keep-out signals. It remains to be determined
whether lactoferrin may be ‘‘disabled’’ in necrotic cells that promote inflam-
mation.
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phils. The purpose of neutrophil attraction is unclear at this time.
How Are the Find-Me Signals Released?
One of the key features of find-me signals is that they are
released when the apoptotic cells are still intact such that the
released mediators can attract the phagocytes, which in turn
would clear the apoptotic cells before they become secondarily
necrotic. This implies that there has to be mechanisms in place
that allow the direct or indirect generation and release of find-
me signals that are coupled to induction of apoptosis. At present,
we do not know how LPC is released fromdying cells. The gener-
ation of S1P as reported by Weigert et al. (2010) appears to
involve caspase-1-dependent release of a fragment of Sphingo-
sine kinase 2 (SphK2), which in turn would generate S1P. During
apoptosis, a specific cleavage site in SphK2 results in a fragment
of this enzyme retaining its enzymatic property. It was also
suggested that this cleaved fragment of SphK2, presumably
by binding to phosphatidylserine (PtdSer) on the inner leaflet
of the plasma membrane, could be ‘‘released’’ from dying
cells when the PtdSer is flipped to the outer leaflet during
apoptosis. SphK2 release into the extracellular space would
then generate S1P. The timing of caspase-dependent cleavage
of SphK2 versus the exposure of phosphatidylserine (PtdSer)
and the generality of thismechanism for other forms of apoptosis
remain to be determined. For fractalkine release, Truman et al.
(2008) suggested that the 60 kDa fragment of fractalkine was
released as microparticles from early stages of apoptotic Burkitt
Lymphoma cells. Themicroparticles were annexin V positive and
the study suggested that they may be generated at the same
time as PtdSer exposure.
The mechanism of nucleotide release during apoptosis has
been better defined (Chekeni et al., 2010). Nucleotides are
released through PANX1, a member of the pannexin family of
channels on the plasma membrane. PANX1 is a four transmem-
brane protein (probably functioning as homo-hexamers) forming
large pores that allow molecules up to 1 kDa to pass through the
plasma membrane (D’hondt et al., 2009). Silencing of PANX1
expression results in loss of nucleotide release from apoptotic
cells, whereas overexpression of PANX1 strongly enhances the
nucleotide release during apoptosis (Chekeni et al., 2010) and
results in better recruitment of monocytes. Moreover, PANX1
currents are detectable upon induction of apoptosis, and this
correlates with plasma membrane permeability. The uptake of
dyes such as YO-PRO1 (and TO-PRO3), which have long been
used to track plasma membrane permeability of early apoptotic
cells, is dependent on PANX1 (Chekeni et al., 2010). Mechanis-
tically, it was demonstrated that the C-terminal tail of PANX1
itself is a target of caspsase-dependent cleavage (by caspases
3 and 7). Mutation of the caspase cleavage site within PANX1
results in failure of nucleotide release, whereas truncation of
PANX1 at the cleavage site leads to a constitutively active
protein (Chekeni et al., 2010). In subsequent work, V. Dixit and
colleagues (Qu et al., 2011) demonstrated that cells from mice
with a genetic ablation of Panx1 are defective in nucleotide
release during apoptosis as well as in recruiting macrophages.
Thus, a model has emerged where apoptotic cells release the
nucleotides ATP and UTP at the earliest stages of apoptosis
via caspase-dependent cleavage and opening or activation of
PANX1 (Figure 2). These nucleotides are then sensed by P2Y2448 Immunity 35, October 28, 2011 ª2011 Elsevier Inc.(and possibly other P2Y family members) and lead to migration
of monocytes to the proximity of apoptotic cell clearance.
Other Roles for Find-Me Signals besides Phagocyte
Attraction?
In addition to establishing a chemotactic gradient to aid in the
location of the dying cells, find-me signals may also modulate
the phagocytic activity of cells in the direct vicinity of the
apoptotic cells. This becomes relevant when one considers
situations where the dying cell is probably eaten by a neighbor
(not a recruited phagocyte), yet releases find-me signals. For
example, apoptotic airway epithelial cells release nucleotides
(Elliott et al., 2009), yet neighboring epithelial cells can engulf
other dying epithelial cells without any migration to the prey.
This raises the question whether find-me signals have other roles
besides recruiting phagocytes. An interesting possibility is that
the find-me signals such as nucleotides or S1P could ‘‘activate’’
or ‘‘prime’’ phagocytes and improve their phagocytic capacity.
In flies, apoptosis in the context of a tissue enhances the
capacity of engulfment by the neighboring cells—for example,
by inducing the upregulation of the engulfment machinery
(MacDonald et al., 2006; Ziegenfuss et al., 2008). In mammals,
the ‘‘bridging’’ molecule MFG-E8 (which binds to PtdSer on
apoptotic cells and facilitates engulfment by engaging the integ-
rin avb3 on phagocytes, see below) is expressed by activated but
not resting macrophages (Hanayama et al., 2002), and it has
been demonstrated that the find-me signal fractalkine can
induce production of the bridging molecule MFG-E8 by macro-
phages (Miksa et al., 2007). One possibility is that the find-me
signals are like a smell of food that increases the appetite of the
phagocyte by upregulating the engulfment machinery compo-
nents. If this were to be applicable to other cell types beyond
macrophages, such as epithelial cells, perhaps some find-me
signals do not act as the final call for a phagocyte, but rather
help boost the engulfment machinery in the neighbor and
thereby actively promote its own clearance.
ATP has been typically thought of as a danger signal (Traut-
mann, 2009) and has been linked to recruitment of neutrophils
during inflammatory conditions and for inducing antitumor
immunity (Aymeric et al., 2010). Yet, apoptotic cell supernatants
appear to preferentially recruit monocytes over neutrophils
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Figure 3. PANX1-Dependent Release of Nucleotides from Apoptotic Cells
A specific proteolytic site within the cytoplasmic tail of PANX1 has been identified as a target of executioner caspases 3 and 7 during apoptosis (scissors). This
leads to opening of the channel and the release of nucleotides ATP and UTP from the apoptotic cells. Please note that PANX1 is thought to function as a hexamer
and that the multisubunit complex forms a channel through which nucleotides are released across the plasma membrane.
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Reviewin vivo (Elliott et al., 2009), and the apoptotic cell clearance is
usually anti-inflammatory and immunologically silent (Fadok
et al., 1998b; Voll et al., 1997). There are perhaps several differ-
ences between the regulated release of nucleotides during
apoptosis and cytolysis (such as necrosis). Less than 2% of total
cellular ATP is released via PANX1 by early apoptotic cells
(Chekeni et al., 2010; Elliott et al., 2009), whereas damage-
induced loss of membrane integrity may release a much higher
quantity of nucleotides. Also, the notion of ATP as an inflamma-
tory molecule derives from its ability to activate the ionotropic
nucleotide receptor P2X7, which in turn results in activation of
the inflammasome and release of proinflammatory cytokines
(Bours et al., 2006; Di Virgilio, 2007). In fact, ATP derived from
necrotic cells has been shown to result in sterile inflammation
via inflammasome activation (Iyer et al., 2009). However, much
higher ATP concentrations are necessary for P2X7 activation
(EC50 > 100 mM) than those necessary for activation of the recep-
tors mediating monocyte chemotaxis (such as P2Y2; EC50 <
1 mM) (Bours et al., 2006; Trautmann, 2009). Although early
in vitro studies link ATP release via Panx1 to P2X7 activation,
Dixit and colleagues (Qu et al., 2011) have now clearly shown
(via Panx1-ablated mice) that Panx1 is dispensable for P2X7
and inflammasome activation. Interestingly, lower concentra-
tions of ATP have been shown to have an anti-inflammatory
effect by suppressing the secretion of inflammatory cytokines,
while promoting the release of anti-inflammatory cytokines (Di
Virgilio, 2007; Hasko´ et al., 2000; la Sala et al., 2001; Wilkin
et al., 2002). Therefore, the concept of ATP as a universal danger
signal might be too simplistic. How nucleotides and other find-
me signalsmay influence immunogenic versus nonimmunogenic
responses to apoptotic cells remains to be better examined
(Green et al., 2009; Zitvogel et al., 2010).
Keep-Out Signals
The apoptotic cell clearance process is generally anti-inflamma-
tory or nonphlogistic, with recruitment predominantly of mono-
cytes and minimal neutrophils or inflammatory cells. Yet, noneof the find-me signals discussed above are specific for mono-
cytes alone. In fact, nucleotides have been long known to facili-
tate migration of neutrophils (directly or indirectly). Yet, when
apoptotic cell supernatants are injected in the airpouch model,
monocytes are predominantly recruited in a nucleotide-depen-
dent manner, with minimal recruitment of neutrophils; under
the same assay when bacterial lipopolysaccharide (LPS) is
injected, neutrophils are predominantly recruited (Elliott et al.,
2009). How is this possible? Gregory and colleagues have
made an interesting observation that apoptotic cell supernatants
also contain keep-out signals for neutrophils (Bournazou et al.,
2009). Specifically, they identified that lactoferrin is released
from apoptotic cells (in a caspase-dependent process) and
that lactoferrin can act as a potent stop signal for neutrophil
migration toward many other chemokines. Lactoferrin does not
inhibit monocyte migration under these conditions. Although
the receptor(s) and the intracellular signals that mediate the
neutrophil migration arrest are not known, this work suggested
that apoptotic cells release both find-me signals and keep-out
signals that preferentially recruit monocytes and/or facilitate
the noninflammatory clearance of the dying cells (Figure 3).
Eat-Me Signals: The Beginnings of a Good
Apoptotic Meal
Although the find-me signals help bring phagocytes to the prox-
imity of the dying cell, the phagocyte still has to specifically iden-
tify the dying cell among the sea of living ones. This requires that
the apoptotic cells express specific markers on their surface
(eat-me signals) for recognition via specific receptors on the
phagocytes. By analogy, whereas the find-me signals are similar
to a fire alarm that brings the fire rescue squad to the street
where a particular house is on fire, pinpointing the house in
trouble would require detecting the fire itself (i.e., eat-me
signals). At present many eat-me signals have been recognized
as being exposed on the surface of apoptotic cells. These
include exposure of PtdSer, changes in charge and glycosylationImmunity 35, October 28, 2011 ª2011 Elsevier Inc. 449
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Reviewpatterns on the cell surface, alteration in intercellular adhesion
molecule-1 (ICAM-1) epitopes on the cell surface, and exposure
of the endoplasmic reticulum-resident protein calreticulin
(Lauber et al., 2004; Nagata et al., 2010).
Among these, the exposure of PtdSer on the outer leaflet
of the plasma membrane has received the most attention
(Fadok et al., 1992, 2001). In fact, PtdSer exposure is the most
universally seen alteration on the surface of apoptotic cells,
observed in many different cell types after multiple modalities
of apoptosis induction. PtdSer exposure is perhaps the generally
accepted definition for calling a cell apoptotic (Fadok et al.,
1998a). However, as discussed below, PtdSer exposure alone
may not be sufficient and PtdSer may work in conjunction with
other eat-me markers to facilitate specific recognition of an
apoptotic cell by a phagocyte. In the section below, I have
detailed some of the recent information on PtdSer exposure
and its recognition by engulfment receptors. For amore thorough
discussiononall of the other eat-mesignals, the reader is referred
to some of the other more detailed reviews (Gardai et al., 2006;
Lauber et al., 2004; Nagata et al., 2010; Savill et al., 2002).
PtdSer Exposure: Common Principles and Some
Complications
PtdSer is normally found on the inner leaflet of the plasma
membrane in healthy cells with very little exposure on the outer
leaflet of most healthy cells (Fadok et al., 1992, 1998a). However,
when the cells are induced to undergo apoptosis, there is a
dramatic change in the amounts of PtdSer exposed on the outer
leaflet (Fadok et al., 1992, 1998a). One of the fascinating things
about PtdSer exposure is that it occurs very early during the apo-
ptosis program (i.e., on apoptotic cells that retain their membrane
integrity) and is readily detectable bymany commercially available
preparations of annexin V, aswell as antibodies that recognize the
PtdSer head group. V. Kagan and colleagues (Borisenko et al.,
2003) quantitated the number of endogenous PtdSer molecules
exposed on Jurkat T cells during apoptosis. Whereas live cells
have minimal PtdSer (<0.9 picomoles/million cells), Jurkat cells
undergoing apoptosis (either by anti-Fas or camptothecin) dis-
played >240 picomoles/million cells of PtdSer on the surface.
This translates to roughly >280-fold increase between apoptotic
and live cellswith respect toPtdSer exposure, and this is achieved
very early in the apoptotic process (1–2 hr after apoptosis induc-
tion) (Borisenko et al., 2003). This change inPtdSer concentrations
on the outer leaflet is proposed to provide the ‘‘specificity’’ for
phagocyte recognitionof anapoptotic cell.Maskingphosphatidyl-
serine on apoptotic cells either through soluble annexin V of
soluble fragments of engulfment receptors or bridging molecules
that recognize PtdSer (see below) blocks phagocytosis of
apoptotic cells. Because many cell types expose PtdSer during
apoptosis and blocking PtdSer attenuates engulfment, it has
clearly been established that phosphatidylserine represents an
essential eat-me signal for clearance of apoptotic cells.
However, the question that has repeatedly arisen over re-
cent years is whether phosphatidylserine exposure is sufficient
for phagocytic uptake (Ravichandran, 2010). In early studies,
because liposomes containing PtdSer are taken up preferentially
(over phosphatidylcholine) and could elicit certain responses
of apoptotic cells from macrophages, phosphatidylserine expo-
sure alone was considered sufficient. However, some other
studies have also suggested that even when PtdSer is artificially450 Immunity 35, October 28, 2011 ª2011 Elsevier Inc.incorporated into the outer leaflet of live cells, phagocytes
fail to engulf them (Borisenko et al., 2003). Interestingly, many
cell types such as macrophages and activated lymphocytes
routinely expose PtdSer sufficient for detection (via annexin V),
yet are spared from engulfment (Dillon et al., 2000; Hamon et al.,
2000). Most recently, Nagata and colleagues (Suzuki et al.,
2010) identified a new calcium-dependent phospholipid scram-
blase (TMEM16F) that could promote the exposure of PtdSer on
live BaF3 cells (in the presence of calcium addition); however,
despite the PtdSer exposure, these cells are not taken up by
macrophages. This suggests that phosphatidylserine alone is
not sufficient. The simplest interpretation of the data is that PtdSer
onapoptoticcells is recognizedbyphagocytes inconjunctionwith
one or more of the other eat-me signals exposed on apoptotic
cells. What these other eat-me signals are remain to be precisely
established. To date, there has only been one such second signal
identified.CalreticulinwassuggestedbyGardai andHenson (Gar-
dai et al., 2005) as a possible second ligand that works together
with PtdSer, but this remains to be better defined. However, cal-
reticulin can also be recognized directly, and the literature report-
ing the exposure of this molecule is variable depending on the
nature of cell death and its immunogenicity (Green et al., 2009;
Gregory and Brown, 2005; Zitvogel et al., 2010).
There are also other possibilities why forced expression of
PtdSer on the outer leaflet may not be sufficient for engulfment.
It appears that a threshold increase of PtdSer molecules (8-fold
over basal state) needs to be exposed before an apoptotic cell
becomes a target for macrophage-mediated phagocytosis
(Borisenkoetal., 2003).Wedonot haveenoughquantitative infor-
mation on the number of PtdSermolecules exposed by activated
lymphocytes or in BaF3 cells overexpressing TMEM16F (Suzuki
et al., 2010). The requirement for a high increase in PS exposure
could allow for small amounts of PS exposure to participate in
other biological functions in nonapoptotic signaling. Another
important consideration is that live cells express ‘‘don’t eat-
me’’ signals that may need to be turned off during apoptosis to
allow recognition by phagocytes. For example, CD47 and CD31
have both been independently suggested to inhibit engulfment
of healthy cells (Brown et al., 2002; Gardai et al., 2005). The pres-
ence or absence of CD47 has also been reported to even alter the
display of PtdSer on the cell surface. Another point to consider is
that during apoptosis, at least a fraction of the exposed PtdSer
may be oxidized or modified in other ways (Tyurin et al., 2008).
Some PtdSer recognition mechanisms (such as CD36 and
MFG-E8) may ‘‘prefer’’ oxidized PtdSer (Borisenko et al., 2004;
Fadeel et al., 2007; Tyurin et al., 2008). If this were the case,
then live cells that expose phosphatidylserine (independent of
apoptosis) or support the synthetic conditions discussed above
may not be comparable to exposure of phosphatidylserine by
apoptotic cells (Appelt et al., 2005). Therefore, the threshold of
phosphatidylserine exposure, other eat-memarkers on the dying
cells, as well as the don’t eat-me signals could all regulate how
phosphatidylserine is recognized by phagocytes. It is important
to note that these are not mutually exclusive possibilities and
couldall contribute to thespecificphosphatidylserine-dependent
recognition of apoptotic cells by phagocytes.
Engulfment Receptors
Studies from a number of laboratories over many years have
identified a multitude of engulfment receptors on phagocytes
Figure 4. Direct and Indirect Recognition of Phosphatidylserine on
Apoptotic Cells
Two modes of recognition of PtdSer exposed on apoptotic cells involve the
direct recognition by phagocytic receptors such as BAI1, TIM-4, and Stabilin 2,
and the indirect recognition where bridging molecules such as MFG-E8 and
Gas6 bind PtdSer that are in turn recognized by membrane proteins such as
MER and avb3. The two modes of recognition are not mutually exclusive and
probably occur simultaneously. Also, for the sake of clarity only the PtdSer
recognition is shown here, but there are number of other ligands on apoptotic
cells, and their cognate receptors on phagocytes have also been identified that
may also participate in the specific recognition process.
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apoptotic cells. These include Scavenger receptors, lectins,
complement receptors, oxidized low density lipoprotein (ox-
LDL) recognizing receptors, CD14, CD36, CD68, LDL-receptor
related protein, tyrosine kinases of the Tyro3-Axl-Mer family,
as well as several other recent PtdSer recognition receptors
(see below). Why we need so many receptors is an open ques-
tion. The consensus in the field has been that not all receptors
are expressed on a given phagocyte, and therefore multiple
modes of recognition are necessary (Henson et al., 2001a; Savill
and Fadok, 2000). Similarly, depending on the nature of the
induction of apoptosis, there may be differences in exposure
of eat-me signals that in turn may dictate the usage of particular
combination of engulfment receptors by a given phagocyte. A
number of years ago, Peter Henson (Henson et al., 2001b) sug-
gested a model of ‘‘tethering and tickling’’ that in the context of
multiple different engulfment receptors binding to varied ligands
on apoptotic cells, some may serve only an adhesion function,
whereas the others may mediate signaling (similar to the situa-
tion that is well established when T cells engage an antigen-pre-
senting cell).
Over the past decade, there has been a significant change in
the thinking about how phagocytes recognize PtdSer on
apoptotic cells. It was initially thought that there would be
a ‘‘single’’ PtdSer recognition receptor universally used by all
phagocytes (Henson et al., 2001b). Now it appears that there
are multiple distinct receptors on phagocytes capable of recog-
nizing PtdSer (Bratton and Henson, 2008). The PtdSer recogni-
tion receptors appear to come in two kinds—those that are
membrane proteins that can directly bind and recognize PtdSer
and those that indirectly recognize PtdSer through binding of
soluble bridging molecules (Figure 4). The PtdSer receptors
capable of directly recognizing PtdSer include members of the
T cell immunoglobulin and mucin (TIM) family (TIM-4, as well
as TIM-1 and TIM-3) (DeKruyff et al., 2010; Ichimura et al.,
2008; Kobayashi et al., 2007; Miyanishi et al., 2007; Rodriguez-Manzanet et al., 2010; Santiago et al., 2007; Wong et al.,
2010); brain angiogenesis inhibitor 1 (BAI1), which is a seven
transmembrane protein belonging to the adhesion type II
GPCR family (Park et al., 2007); and the atypical epidermal
growth factor (EGF)-motif containing membrane protein Stabi-
lin-2 (Park et al., 2008).
With respect to indirect recognition of PtdSer on apoptotic
cells, the soluble protein MFG-E8 has garnered the most atten-
tion recently (Akakura et al., 2004; Asano et al., 2004; Hanayama
and Nagata, 2005; Hanayama et al., 2002, 2004; Thorp and
Tabas, 2009). One region of MFG-E8 can bind PtdSer on
apoptotic cells with high affinity (Hanayama et al., 2002, 2004),
whereas a second region of MFG-E8 can simultaneously engage
integrin avb3 on phagocytes; thus, through this bridging function,
MFG-E8 can mediate PtdSer-dependent uptake of apoptotic
cells. In vitro studies coupled with in vivo studies in mouse
models have now established a definitive role for MFG-E8 as
an important bridging molecule. Interestingly, MFG-E8 is not
expressed on resting macrophages, but is upregulated in acti-
vated macrophages. As discussed above, perhaps find-me
signals ‘‘promote’’ expression of MFG-E8 on macrophages.
Two other bridging molecules, Gas6 and Protein S, can also
recognize PtdSer exposed on apoptotic cells; they are in turn
recognized by Tyro-3-Axl-Mer family of receptors (denoted
as TAM receptors) on phagocytes (Lemke and Rothlin, 2008;
Rothlin et al., 2007; Scott et al., 2001). An important role for
this family has been established through single and combined
genetic ablation of the TAM family members in mice; these
receptors appear important for clearance of apoptotic cells in
the eye, testes, thymus, and other tissues (Lemke and Rothlin,
2008; Prasad et al., 2006). In addition to the above receptors
and bridging proteins, the membrane proteins CD36 and CD68
and the soluble thrombospondins (in turn binding to membrane
receptors) have been suggested to be capable of binding
PtdSer (Balasubramanian and Schroit, 1998; Imachi et al.,
2000; Mevorach, 2000; Savill et al., 1991, 1992).
How these various receptors signal intracellularly to mediate
the physical rearrangement of the phagocyte cytoskeleton to
facilitate corpse uptake is not fully defined. It appears that there
is considerable variation even among receptors recognizing
a single ligand PtdSer. The cytoplasmic and transmembrane
regions of TIM-4 appear not necessary for TIM-4-mediated
apoptotic cell uptake (Park et al., 2009), suggesting that TIM-4
may serve only a ‘‘tethering’’ function and use other membrane
receptors for signaling. Similarly, CD36 has a short cytoplasmic
tail (four amino acids) and probably uses other membrane
proteins (such as the vitronectin receptor) for signaling (Albert
et al., 1998; Savill et al., 1992). BAI1 is a 7-transmembrane
protein that signals via the evolutionarily conserved ELMO1-
Dock180-Rac complex (Park et al., 2009) to promote cytoskel-
etal rearrangement. Therefore, the possibility exists that distinct
types of signals emanate within the phagocytes that may help
signal amplification as well as allow a phagocyte to distinguish
between live and apoptotic cells.
Future Challenges
In summary, over the past few years, significant progress has
been inmade in defining find-me and eat-me signals of apoptotic
cells and how they regulate cell clearance in vivo. The newImmunity 35, October 28, 2011 ª2011 Elsevier Inc. 451
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lenges, some of which are discussed below.
Although the concept that the early steps of apoptosis and
phagocytosis are intimately tied (i.e., two sides of the same
coin) originated from the C. elegans studies, to date no find-me
signals have been identified in either C. elegans or Drosophila.
Because neighboring cells usually mediate engulfment of dying
cells in C. elegans, perhaps the motility of phagocytes is not
necessary. However, the hemocytes and glia in Drosophila are
motile and therefore find-me signals could be relevant. The
advantage of the model organisms is that the number of genes
within a functional pathway are often less redundant, thereby
making genetic manipulations of a find-me signal and deter-
mining effects at an organism level probably more amenable.
In contrast, we already know of four or more find-me signals in
the mammalian system and redundancy among them is inevi-
table. Also, the possibility that find-me signals (such as nucleo-
tides, S1P, or fractalkine) could also activate the engulfment
machinery is quite attractive, because this may be more relevant
for situations where the apoptotic cells may need to boost the
engulfment capacity of a neighboring healthy cell. Testing this
possibility initially in model organisms and further in themamma-
lian system (e.g., lung or gut epithelial cells) could prove inter-
esting. Also, although the concept that nucleotides can be
released via pannexin channels during apoptosis is well estab-
lished, it is unclear how apoptotic cells release other find-me
signals or the keep-out signals (such as lactoferrin, a much larger
molecule). Because both find-me and eat-me signals are found
in the same apoptotic cell supernatants, distinct yet cooperative
mechanismsmust exist and these remain to be defined. Also, we
have relatively little knowledge of find-me signals that may be
released in types of cell death other than apoptosis and how
other types of cell death (e.g., necrosis, pyroptosis, cell death
associated with autophagy, etc.) attract phagocytes.
With respect to eat-me signals, although phosphatidylserine
as a key recognition molecule on apoptotic cells is established
beyond doubt, we still have relatively low resolution on the
topology of phosphatidylserine exposed on the apoptotic cells
and how it is engaged by specific engulfment receptors. It is
also puzzling that we have so many engulfment receptors that
can recognize phosphatidylserine, yet whether they simulta-
neously, sequentially, or cooperatively bind the exposed PtdSer
on apoptotic cells is unclear. If these receptors do bind simulta-
neously to PtdSer on apoptotic cells, then how do they avoid
competition among each other and how are steric issues of
recognition resolved? We also do not have much information
on whether PtdSer recognition receptors function as monomers,
dimers, or higher-order oligomers during PtdSer recognition.
Intriguingly, some of the engulfment receptors also appear to
have a soluble version (comprising only the region of PtdSer
binding), and whether these soluble fragments are inhibitors or
promoters of engulfment remains to be determined.
Although the eat-me signals on ‘‘early’’ apoptotic cells have
been the focus here, clearly apoptotic cells that escape detec-
tion by the engulfment machinery could undergo secondary
necrosis. The precise molecular features of late apoptotic cells
and necrotic cells and how the phagocytes may engage them
are just beginning to emerge (Beer et al., 2008; Franz et al.,
2007; Peter et al., 2010a). For example, certain carbohydrate452 Immunity 35, October 28, 2011 ª2011 Elsevier Inc.moieties on late apoptotic cells appear to progressively change
and they also tend to expose molecules generally considered
intracellular (such as endoplasmic reticulum components)
(Beer et al., 2008; Franz et al., 2007). Similarly, annexin I,
exposed on secondarily necrotic cells, appears to block inflam-
matory responses of phagocytes (Blume et al., 2009). How early
apoptotic cells progress to secondarily necrotic cells, how the
pattern of eat-me signals is modified on their surface, and which
phagocyte receptors would mediate their recognition remain to
be determined. Another area to be explored further is the type
of eat-me signals exposed on cells undergoing different types
of cell death and how phagocytes might recognize such eat-
me signals.
Lastly, the signaling via the engulfment receptors needs to be
more systematically analyzed and compared, because this
would have direct relevance for defining the anti-inflammatory
cytokine production downstream of apoptotic cell recognition.
The latter is obviously important for both understanding auto-
immune diseases that arise as a consequence of failed corpse
clearance as well as creating a therapeutic approach to damp-
ening unwanted inflammation in many disease states.
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